Managing recurrent vulvovaginal candidiasis: Intermittent prevention with itraconazole

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 42, Issue 2, 1997, Pages 83-87

  Spinillo, Arsenio ^a,b   Colonna, Laura ^a   Piazzi, Gaia ^a   Baltaro, Federica ^a   Monaco, Antonio ^a   Ferrari, Antonella ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

candidiasis; itraconazole; vulvovaginal

Indexed keywords

ITRACONAZOLE; KETOCONAZOLE;

ADULT; ARTICLE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RECURRENT INFECTION; VAGINA CANDIDIASIS;

ADULT; ANTIFUNGAL AGENTS; CANDIDIASIS, VULVOVAGINAL; FEMALE; HUMANS; ITRACONAZOLE; RECURRENCE;

EID: 0031037739     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Sobel JD. Candidal vulvovaginitis. Clin Obstet Gynecol 1993;36:153-165
2. Spinillo A, Pizzoli G, Colonna L, et al: Epidemiologic characteristics of women with idiopathic recurrent vulvovaginal candidiasis. Obstet Gynecol 1993;81:721-727
3. Sobel JD: Management of recurrent vulvovaginal candidiasis with intermittent ketoconazole prophylaxis. Obstet Gynecol 1985;65:435-440
4. Sobel JD: Recurrent vulvovaginal candidiasis: A prospective study of the efficacy of maintenance ketoconazole therapy. N Engl J Med 1986;315:1455-1458
5. Baldson MJ, Tobin JM: Recurrent vaginal candidosis: Prospective study of effectiveness of maintenance miconazole treatment. Genitourin Med 1988;64:124-127
6. Sobel JD, Schmitt C, Meriwether C: Clotrimazole treatment of recurrent and chronic candida vulvovaginitis. Obstet Gynecol 1989;73:330-334
7. Sobel JD, Muller G: Comparison of itraconazole and ketoconazole in the treatment of experimental candidal vaginitis. Antimicrob Agents Chemother 1984;26:266-267
8. Larosa E, Cauwenberg G, Cilli P, et al: Itraconazole pharmacokinetics in the female genital tract: Plasma and tissue levels in patients undergoing hysterectomy after a single dose of 200 mg itraconazole. Eur J Obstet Gynecol Reprod Biol 1986;23:85-89
9. Heykants J, Van Peer A, Lavrijsen K, et al: Pharmacokinetics of oral antifungals and their clinical implications. Br J Clin Pract (suppl 9) 1990;44:50-56
10. Amsel R, Totten PA, Spiegel CA, et al: Nonspecific vaginitis: Diagnostic criteria and microbial and epidemiological associations. Am J Med 1983;74:14-22
11. Van Heudsen AM, Merkus JMWM: Chronic recurrent vaginal candidosis: Easy to treat, difficult to cure: Results of intermittent treatment with a new oral antifungant. Eur J Obstet Gynecol Reprod Biol 1990;35:75-83
12. Spinillo A, Carratta L, Pizzoli G, et al: Recurrent vaginal candidiasis. Results of a cohort study of sexual transmission and intestinal reservoir. J Reprod Med 1992;37:343-347
13. Van Cutsem J: The in-vitro antifungal spectrum of itraconazole. Mycoses (suppl 1) 1989;32:7-13
14. Masterton G, Napier IR, Henderson JN, et al: Three-day clotrimazole treatment in candidal vulvovaginitis. Br J Vener Dis 1977;53:126-128